Ultragenyx Pharmaceutical Inc. (RARE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ultragenyx Pharmaceutical...

    NASDAQ: RARE · Real-Time Price · USD
    31.21
    0.31 (1.00%)
    At close: Oct 03, 2025, 3:59 PM
    30.61
    -1.92%
    After-hours: Oct 03, 2025, 06:56 PM EDT

    Ultragenyx Pharmaceutical Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 173.73M 213.58M 132.94M 307.58M
    Short-Term Investments
    		 436.3M 363.63M 614.82M 432.61M
    Long-Term Investments
    		 135M 199.9M 154.5M 293.86M
    Other Long-Term Assets
    		 62.68M 57.69M 10.7M 11.62M
    Receivables
    		 121.8M 73.39M 40.45M 28.43M
    Inventory
    		 45.01M 33.97M 26.77M 16.23M
    Other Current Assets
    		 40.29M 47.62M 68.93M n/a
    Total Current Assets
    		 817.12M 732.18M 883.9M 856.6M
    Property-Plant & Equipment
    		 265.93M 290.57M 285.69M 176.18M
    Goodwill & Intangibles
    		 222.72M 210.68M 204.51M 175.19M
    Total Long-Term Assets
    		 686.33M 758.83M 661.54M 665.79M
    Total Assets
    		 1.5B 1.49B 1.55B 1.52B
    Account Payables
    		 38.76M 42.11M 43.27M 17.14M
    Deferred Revenue
    		 n/a n/a 1.48M 7.61M
    Short-Term Debt
    		 10.3M n/a 11.78M 11.07M
    Other Current Liabilities
    		 151.23M 142.79M 113.96M 71.9M
    Total Current Liabilities
    		 344.15M 280.44M 261.21M 181.37M
    Long-Term Debt
    		 n/a n/a n/a 351.79M
    Other Long-Term Liabilities
    		 836.91M 904.59M 880.26M 1M
    Total Long-Term Liabilities
    		 897.01M 935.16M 931.74M 418.47M
    Total Liabilities
    		 1.24B 1.22B 1.19B 599.84M
    Total Debt
    		 910.01M 43.17M 31.59M 41.97M
    Book Value
    		 262.3M 275.41M 352.49M 922.56M
    Book Value Per Share
    		 2.90 3.74 5.04 13.61
    Common Stock
    		 92K 82K 70K 69K
    Retained Earnings
    		 -3.96B -3.39B -2.78B -2.07B
    Comprehensive Income
    		 -643K 647K -6.57M -1.4M
    Shareholders Equity
    		 255.3M 275.41M 352.49M 922.56M
    Total Investments
    		 571.3M 563.53M 620.35M 726.47M

    Add to Watchlist